BioCentury
ARTICLE | Financial News

Alexar debuts with $21.5 million in series A

January 3, 2014 12:53 AM UTC

Alexar Therapeutics Inc. (Malvern, Pa.) debuted with $21.5 million secured in a series A round led by New Science Ventures and Third Point Ventures. Palo Alto Investors also participated. Alexar is de...